Pembrolizumab Promising for Metastatic Head, Neck SCC
THURSDAY, Dec. 20, 2018 -- For patients with recurrent or metastatic head and neck squamous cell carcinoma, pembrolizumab has a favorable safety profile and is associated with prolongation of overall survival, according to a study published online...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cancer & Oncology | Carcinoma | HNSCC | Pharmaceuticals | Skin Cancer | Squamous Cell Carcinoma | Study